Multifunctional role of matrix metalloproteinases in multiple myeloma -: A study in the 5T2MM mouse model

被引:38
作者
Van Valckenborgh, E
Croucher, PI
De Raeve, H
Carron, C
De Leenheer, E
Blacher, S
Devy, L
Noël, A
De Bruyne, E
Asosingh, K
Van Riet, I
Van Camp, B
Vanderkerken, K
机构
[1] Free Univ Brussels, Dept HEIM, B-1090 Brussels, Belgium
[2] Univ Antwerp, Dept Pathol, Edegem, Belgium
[3] Univ Liege, Lab Biol Tumour & Dev, Liege, Belgium
[4] Univ Sheffield, Sch Mat, Div Clin Sci S, Sheffield, S Yorkshire, England
[5] Pfizer, St Louis, MO USA
关键词
D O I
10.1016/S0002-9440(10)63349-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
matrix metalloproteinases (mmPs) are known to play a role in cell growth, invasion, angiogenesis, metastasis, and bone degradation, all important events in the pathogenesis of cancer. Multiple myeloma is a B-cell cancer characterized by the proliferation of malignant plasma cells in the bone marrow, increased angiogenesis, and the development of osteolytic bone disease. The role of MMPs in the development of multiple mycloma is poorly understood. using sc-964, a potent 'inhibitor of several MMPS (MMP-2, -3, -8, -9, and -13), we investigated the role of MMPs in the 5T2MM Murine modeL Reverse transcriptase-polymerase chain reaction demonstrated the presence of mRNA for MMP-2, -8, -9, and -13 in 5T2MM-diseased bone marrow. Mice bearing 5T2MM cells were given access to food containing SC-964. The concentration of SC-964 measured in the plasma of mice after 11 days of treatment was able to inhibit MMP-9 activity in gelatin zymography. Treatment of 5T2MM-bearing mice resulted in a significant reduction in tumor burden, a significant decrease in angiogenesis, and partially protective effect against the development of osteolytic bone disease. The direct role of MMPs in these different processes was confirmed by in vitro experiments. All these results support the multMinctional role of mmPs in the development of multiplemyeloma.
引用
收藏
页码:869 / 878
页数:10
相关论文
共 50 条
[1]  
Ahonen M, 1998, CANCER RES, V58, P2310
[2]  
Arlt M, 2002, CANCER RES, V62, P5543
[3]   Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma [J].
Asosingh, K ;
Menu, E ;
Van Valckenborgh, E ;
Vande Broek, I ;
Van Riet, I ;
Van Camp, B ;
Vanderkerken, K .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) :583-591
[4]  
Asosingh K, 2000, Hematol J, V1, P351, DOI 10.1038/sj.thj.6200052
[5]  
Barillé S, 1999, J IMMUNOL, V163, P5723
[6]   Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells [J].
Barille, S ;
Akhoundi, C ;
Collette, M ;
Mellerin, MP ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 1997, 90 (04) :1649-1655
[7]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[8]   Improved quantification of angiogenesis in the rat aortic ring assay [J].
Blacher S. ;
Devy L. ;
Burbridge M.F. ;
Roland G. ;
Tucker G. ;
Noël A. ;
Foidart J.-M. .
Angiogenesis, 2001, 4 (2) :133-142
[9]   TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis [J].
Bloomston, M ;
Shafii, S ;
Zervos, EE ;
Rosemurgy, AS .
JOURNAL OF SURGICAL RESEARCH, 2002, 102 (01) :39-44
[10]  
CARRON CP, 2001, P AM ASS CANC RES AN, V42, P4975